Pathogenic virus-specific T cells cause disease during treatment with the calcineurin inhibitor FK506: implications for transplantation.
Pathogenic virus-specific T cells cause disease during treatment with the calcineurin inhibitor FK506: implications for transplantation.
复制标题
DOI:
10.1084/jem.20100124
复制
发表时间:
2010-10-25
期刊:
影响因子:
--
通讯作者:
Ahmed R
中科院分区:
文献类型:
--
作者:
Araki K;Gangappa S;Dillehay DL;Rouse BT;Larsen CP;Ahmed R
Pathogenic virus-specific T cells can inflict a cytokine storm and lethal disease even in immunosuppressive conditions. Recently, several cases of fatal lymphocytic choriomeningitis virus (LCMV) infection occurred in transplant recipients being treated with the immunosuppressive calcineurin inhibitor FK506. These findings were surprising because LCMV is a noncytolytic virus. To understand how a noncytolytic virus can cause disease under conditions of immunosuppression, we used the mouse LCMV model and found that, similar to the observations in human transplant recipients, LCMV infection of FK506-treated mice resulted in a lethal disease characterized by viremia, lack of seroconversion, and minimal lymphocytic infiltrates in the tissues. However, despite the apparent absence of an antiviral immune response, this disease was orchestrated by virus-specific T cells. FK506 did not prevent the generation and proliferation of LCMV-specific T cells but instead altered their differentiation so that these effector T cells lost the ability to control virus but were still capable of mediating disease. These pathogenic T cells initiated a cytokine storm characterized by high levels of tumor necrosis factor (TNF) and interleukin 6 (IL-6), and depletion of T cells or blockade of these inflammatory cytokines prevented the lethal disease. Our study shows that inhibiting calcineurin can generate pathogenic T cells and indicates that T cell–mediated viral disease can occur even under conditions of immunosuppression. Furthermore, we identify a potential strategy (blockade of TNF and IL-6) for treatment of transplant recipients who have acute complications of viral infection.
登录
查看更多内容
影响因子:
4.4
作者:
Grayson, JM;Harrington, LE;Ahmed, R
通讯作者:
Ahmed, R
DOI:
10.1084/jem.20061496
发表时间:
2006-10-02
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Petrovas C;Casazza JP;Brenchley JM;Price DA;Gostick E;Adams WC;Precopio ML;Schacker T;Roederer M;Douek DC;Koup RA
通讯作者:
Koup RA
DOI:
10.1084/jem.20050821
发表时间:
2005-09-05
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Kolumam GA;Thomas S;Thompson LJ;Sprent J;Murali-Krishna K
通讯作者:
Murali-Krishna K
影响因子:
64.8
作者:
Araki, Koichi;Turner, Alexandra P.;Shaffer, Virginia Oliva;Gangappa, Shivaprakash;Keller, Susanne A.;Bachmann, Martin F.;Larsen, Christian P.;Ahmed, Rafi
通讯作者:
Ahmed, Rafi
DOI:
10.1084/jem.186.9.1407
发表时间:
1997-11-03
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Hamann D;Baars PA;Rep MH;Hooibrink B;Kerkhof-Garde SR;Klein MR;van Lier RA
通讯作者:
van Lier RA